Angelman syndrome

Showing 1 posts of 1 posts found.

shutter

Ovid’s Angelman syndrome therapy falls short at Phase 3

December 2, 2020
Research and Development Angelman syndrome, Ovid

Ovid Therapeutics has revealed disappointing results for its therapy OV101 (gaboxadol) in the treatment of Angelman syndrome, admitting that it failed …

Latest content